Clinical Trial Update: Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial update for apixaban in preventing stroke in atrial fibrillation. The ARISTOTLE trial has completed and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 3 | Status: COMPLETED | Results posted: 2013-04-29